🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04206852
Recruiting Observational

Safety and Efficacy of Balloon Pulmonary Angioplasty in China

NCT04206852 · tracked via the Priya Life Science China tracker
Sponsor
Chinese Pulmonary Vascular Disease Research Group
Phase
Observational
Started
2018-05-11
Last updated
2023-12-20

Condition(s) studied

Chronic Thromboembolic Pulmonary Hypertension

Investigational drug(s) / intervention(s)

Balloon pulmonary angioplasty

Balloon pulmonary angioplasty: Balloon pulmonary angioplasty is an interventional technique where a balloon catheter is used to recanalize affected segments of pulmonary arteries identified during angiography.

Study summary

Balloon pulmonary angioplasty (BPA) is a potential treatment for non-operable patients with chronic thromboembolic pulmonary hypertension (CTEPH).

The aim of this study was to evaluate the safety and efficacy of BPA in CTEPH patients not amenable to pulmonary endarterectomy(PEA) or suffered from persistent CTEPH after PEA.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. diagnosed with CTEPH according to ESC Guidelines (1) Mean PAP ≥ 25mmHg at rest; or if mean PAP \< 25mmHg at rest, have exercise limitations from chronic thromboembolic disease (2)Abnormal ventilation perfusion lung scanning (VQ) scan, pulmonary angiogram, computer tomographic pulmonary angiogram, or magnetic resonance pulmonary angiogram confirming chronic thromboembolic disease as recommended by standard guidelines 2. Treatment with anticoagulation for ≥ 3 months before diagnosis of CTEPH 3. Not amenable to pulmonary endarterectomy 4. Willing to provide informed consent Exclusion Criteria: 1. Patients unwilling or unable to provide written consent for participation in the study. 2. Impossible to follow up.

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
center of pulmonary vascular disease, Fuwai hospital Beijing China Recruiting
Chinese Academy of Medical Sciences Fuwai hospital Beijing China Recruiting

More Chinese Pulmonary Vascular Disease Research Group trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04206852 on ClinicalTrials.gov ↗ ← All trials in China